Posts

Playing in the hot obesity market, Carmot braves chilly IPO waters

,

Armed with a pipeline of obesity and diabetes hopefuls, Carmot Therapeutics joins the small group of biotechs to attempt a Nasdaq debut this year.

Read more
/by